Water Island Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-649,242
Closed -$44.2M 125
2022
Q3
$44.2M Buy
+649,242
New +$35.8M 2.5% 17

Other funds holding GBT

Water Island Capital's GBT Position: Q4 2022 in Review

Water Island Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 649,242 shares — an estimated $44.2M sold.

Water Island Capital first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $44.2M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Water Island Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Water Island Capital sold 649,242 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $44.2M.
  • Water Island Capital first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Water Island Capital's Global Blood Therapeutics, Inc. position peaked at $44.2M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Water Island Capital's 13F filing for Q4 2022, filed 14 Feb 2023.